Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2000
07/20/2000WO2000041558A2 Interspecific nicotiana hybrids and their progeny
07/20/2000WO2000041549A2 Binary probe and clamp composition and methods for target hybridization detection
07/20/2000WO2000041545A2 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000WO2000041524A2 Isothermal amplification of dna
07/20/2000WO2000041516A2 Reagents and methods useful for detecting diseases of the breast
07/20/2000WO2000041509A2 Polypeptides having acid phosphatase activity and nucleic acids encoding same
07/20/2000WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
07/20/2000WO2000041477A2 Production of heterologous proteins from zygosaccharomyces bailii
07/20/2000WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor
07/20/2000WO2000031141B1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof
07/20/2000WO2000028031A8 Mitogenic regulators
07/20/2000WO2000027437A3 Polymer grafting by polysaccharide synthases
07/20/2000WO2000026230A8 Low allergenic protein variants
07/20/2000WO2000024885A3 p53 MORPHOLINO-BASED ANTISENSE
07/20/2000WO2000023591A3 Secreted protein zsig49
07/20/2000WO2000022132A3 Nucleic acids that control reproductive development in plants
07/20/2000WO2000020590A3 G-protein coupled receptor proteins
07/20/2000WO2000020589A3 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER
07/20/2000WO2000020586A3 Renal cancer associated antigens and uses therefor
07/20/2000WO2000020582A3 Gene replacement therapy for muscular dystrophy
07/20/2000WO2000020573A3 Dna shuffling to produce nucleic acids for mycotoxin detoxification
07/20/2000WO2000020572A3 Tissue binding peptides, identification, production and utilization thereof
07/20/2000WO2000020018A8 Kappa-a conopeptides and uses therefor
07/20/2000WO2000017363A3 Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
07/20/2000WO2000017358A3 Human chaperone proteins
07/20/2000WO2000017235A3 Cytokine receptor zalpha11
07/20/2000WO2000015795A3 Genes from human chromosome 11p15.5
07/20/2000WO2000015783A3 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE
07/20/2000WO2000015772A3 Recombinant protein production in urine
07/20/2000WO2000015246A3 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
07/20/2000WO2000013017A3 Method and device for producing and/or analyzing biochemical reaction supporting materials
07/20/2000WO2000012140A8 Method for labeling biopolymers using isotopes
07/20/2000WO2000011446A3 Signal generating oligonucleotide-based biosensor
07/20/2000WO2000008163A3 Aromatic amino acid decarboxylase proteins of a parasitic helminth, nucleic acid molecules coding them, and uses thereof
07/20/2000WO2000004163A9 Tetrahydrofolate metabolism enzymes
07/20/2000WO2000004156A9 SEROTYPE-SPECIFIC PROBES FOR $i(LISTERIA MONOCYTOGENES)
07/20/2000WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer
07/20/2000WO2000003030A3 Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
07/20/2000WO2000003012A9 Expression of eukaryotic peptides in plant plastids
07/20/2000WO2000002950A9 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier
07/20/2000WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth
07/20/2000WO2000002897A9 Delta cleavage products and methods based thereon
07/20/2000WO2000000585A9 MAIZE CYTOCHROME P450 MONOOXYGENASE cDNA (CYP71C3v2)
07/20/2000WO1999067386A8 Differentially expressed genes in pancreatic cancer and displasia
07/20/2000WO1999067373A3 Invertebrate intestinal mucins, cdnas, antibodies and their use
07/20/2000WO1999063094A9 Nucleotide and protein sequences of gpr1 and methods based thereon
07/20/2000WO1999063082A9 Isolation of drosophila homolog to mammalian gdnf
07/20/2000WO1999055882A9 Phytic acid biosynthetic enzymes
07/20/2000WO1999054353A3 Human nucleic acid sequences of normal uterus tissue
07/20/2000WO1999053073A9 Interconversion of plant fatty acid desaturases and hydroxylases
07/20/2000WO1999053046A9 Noncloning technique for expressing a gene of interest
07/20/2000WO1999050409A9 Mixed-backbone oligonucleotides containing pops blocks to obtain reduced phosphorothioate content
07/20/2000WO1997025042A8 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
07/20/2000DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins
07/20/2000DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins
07/20/2000DE19900284A1 Method for introducing DNA into eukaryotic cells, useful in gene therapy, particularly of lymphoma, by incubation with adenovirus
07/20/2000DE19855013A1 Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element Androgen and progesterone receptor binding hormone response element
07/20/2000CA2509345A1 Bacterial cell component-unresponsive model mouse
07/20/2000CA2375769A1 Isothermal amplification of dna
07/20/2000CA2371938A1 Method for electrochemically detecting nucleic acid-oligomer hybridisation events
07/20/2000CA2371752A1 Tumor marker zsig62
07/20/2000CA2370042A1 Regulators of the pct or smoothened pathway, compositions and uses related thereto
07/20/2000CA2362484A1 Herbicide target gene and methods
07/20/2000CA2361204A1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
07/20/2000CA2360597A1 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease
07/20/2000CA2360588A1 Human homologues of proteins regulated by circadian rhythms
07/20/2000CA2360584A1 Mammalian alpha-helical protein - 12
07/20/2000CA2360577A1 Zlrr3: a human leucine-rich repeat protein
07/20/2000CA2360563A1 Novel interferon-.alpha.
07/20/2000CA2360555A1 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome
07/20/2000CA2360549A1 Double nuclear transfer method and results thereof
07/20/2000CA2360464A1 Human peptidases
07/20/2000CA2360387A1 Catalytic molecules
07/20/2000CA2359868A1 Soybean transformation method
07/20/2000CA2359843A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling
07/20/2000CA2359814A1 Method for the affinity isolation of newly synthesized rna
07/20/2000CA2359798A1 Methods of screening protease inhibitors, of inducing mice susceptible to hiv protease inhibitor-induced dyslipidemia, and genes associated therewith
07/20/2000CA2359795A1 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
07/20/2000CA2359629A1 Schizochytrium pks genes
07/20/2000CA2359538A1 Biologically active reverse transcriptases
07/20/2000CA2359504A1 Novel compounds
07/20/2000CA2359492A1 Neisseria meningitidis antigen
07/20/2000CA2359486A1 Neisseria meningitidis polypeptide basb052
07/20/2000CA2359479A1 Novel complex-forming proteins
07/20/2000CA2359474A1 Particles for oral delivery of peptides and proteins
07/20/2000CA2359398A1 Interspecific nicotiana hybrids and their progeny
07/20/2000CA2359396A1 Polynucleotide and method for selectively expressing a protein in a target cell or tissue of a plant
07/20/2000CA2359392A1 Use of apoptosis inducing agents in the treatment of (auto)immune diseases
07/20/2000CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor
07/20/2000CA2359356A1 An expression silencing system and different uses thereof
07/20/2000CA2359349A1 A method for introducing substances into cells, and use of said method
07/20/2000CA2359345A1 Methods for making proteins containing free cysteine residues
07/20/2000CA2359335A1 Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
07/20/2000CA2359132A1 Bone marrow-specific protein
07/20/2000CA2359067A1 Polypeptide variants with altered effector function
07/20/2000CA2358908A1 Bone stimulating factor
07/20/2000CA2358748A1 Reagents and methods useful for detecting diseases of the breast
07/20/2000CA2357726A1 Chorionic gonadotropin dna vaccines and methods
07/20/2000CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor
07/20/2000CA2320714A1 Methods for making character strings, polynucleotides and polypeptides having desired characteristics